HALO logo
halo search icon
Cabaletta Bio, Inc.

US$3.44

Price Change Indicator
0.17 (5.20%)
Cabaletta Bio, Inc.
CABA · NAS

Cabaletta Bio, Inc.

Start Trading CABA for Free

US$3.44

Price Arrow0.17 (5.20%)
20/05/2026 04:00:01 PM
All-CompaniesAll-ConsensusHALO AllHALO Consensus ValueHALO Earnings MomentumHALO MomentumRecent Earnings upgrade
Consensus Score
Lock Icon/10
Recommend
Lock
Target Price
Lock
Deviation
Lock
Unlock Full Consensus Insights

Cabaletta Bio, Inc. Overview

CABA Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Neutral

HALO Model

Mqv

Very Weak

Garp

Very Weak

Mqv Small

Neutral

Valuation

Value

Lock Icon

Consensus

Lock Icon

Momentum

Price

Neutral

Earnings

Very Strong

Growth

Earnings

Strong

Dividends

Very Weak

Quality

Capital Efficiency

Very Weak

Balance Sheet

Very Weak

About CABA

icon
icon

Telephone

1.267.759.3100

icon

Address

Suite 600, 2929 Arch Street, Philadelphia, PA 19104

Description

Cabaletta Bio, Inc. is a clinical-stage biotechnology company, which engages in the discovery and development of engineered T cell therapies for B cell-mediated autoimmune diseases. Its proprietary technology utilizes chimeric autoantibody receptor to selectively bind and eliminate B cells that produce disease-causing autoantibodies. The company was founded by Michael C. Milone, Steven Nichtberger, and Aimee Payne in April 2017 and is headquartered in Philadelphia, PA.

CABA Price Chart

Key Stats

Market Cap

US$533.19M

PE

0.00

EV/EBITDA

N/A

Dividends Overview

DIV Yield

0%

Franking

0%

Ex Dividend Date (est.)

N/A

Market Data

52 weeks range

Low 1.26 - 4.23

Trade Value (12mth)

US$1,979,660.00

1 week

-1.21%

1 month

4.47%

YTD

47.96%

1 year

82.17%

All time high

26.35

Key Fundamentals

EPS 3 yr Growth

16.40%

EBITDA Margin

0.00%

Operating Cashflow

-$131m

Free Cash Flow Return

-96.10%

ROIC

-123.00%

Interest Coverage

-85.10

Quick Ratio

2.80

Other Data

Shares Outstanding (Fully Diluted)

112m

HALO Sector

Healthcare

Next Company Report Date

18-Mar-27

Next Ex Dividend Date

N/A

Next Dividend Pay Date

N/A

Reporting Currency

USD

Short Sell (% of issue)

0.00

CABA Announcements

Latest Announcements

DateAnnouncements
14 May 26
14 May 26
14 May 26
14 May 26
14 May 26

CABA Fundamentals

Per Share Records

Historical data

Forecast data

USD2021202220232024202320242025202620272028
Per Share, Growth & Valuations
EPS (Basic)
 $locklocklocklock-1.65-2.34-2.1locklocklock
EPS (Fully Diluted)
 $locklocklocklock-1.65-2.34-2.1locklocklock
Growth
 %locklocklocklock8.5-41.610.2locklocklock
PE
 XlocklocklocklockN/AN/AN/Alocklocklock
EV/EBITDA
 XlocklocklocklockN/AN/AN/Alocklocklock

Dividends

Key Stats

Ex Dividend Date (est.)

N/A

DIV Yield

0%

Franking Level

0%

DPSg

N/A

Quality Yield

lock

Falling Divs over next 2

lock

Want to learn more?Frequently asked questions.
What is the current share price of Cabaletta Bio, Inc. (CABA:NAS)?
Halo FAQ
The current share price of Cabaletta Bio, Inc. (CABA:NAS) is USD$3.44.
What is the 52-week high share price for Cabaletta Bio, Inc. (CABA:NAS)?
Halo FAQ
The 52-week high share price for Cabaletta Bio, Inc. (CABA:NAS) is USD$4.23.
What is the 52-week low share price for Cabaletta Bio, Inc. (CABA:NAS)?
Halo FAQ
The 52-week low share price for Cabaletta Bio, Inc. (CABA:NAS) is USD$1.26.
What is the dividend yield for Cabaletta Bio, Inc. (CABA:NAS)?
Halo FAQ
Cabaletta Bio, Inc. (CABA:NAS) does not pay a dividend.
What was Cabaletta Bio, Inc. (CABA:NAS) last dividend payment?
Halo FAQ
Cabaletta Bio, Inc. (CABA:NAS) does not pay a dividend.
What is the franking level for Cabaletta Bio, Inc. (CABA:NAS)?
Halo FAQ
Cabaletta Bio, Inc. (CABA:NAS) has a franking level of 0.00%.
In which sector is Cabaletta Bio, Inc. (CABA:NAS) classified?
Halo FAQ
Cabaletta Bio, Inc. (CABA:NAS) is classified in the Healthcare.

See beyond the curve.

One solution for research, investing and portfolio management.
Start FREE Trial